In8Bio Inc (INAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 3,967 | 5,201 | 5,660 | 6,224 | 7,109 |
| Operating Income | -3,967 | -5,201 | -5,660 | -6,224 | -7,109 |
| Other Income | 113 | 107 | 110 | 64 | 23 |
| Pre-tax Income | -3,854 | -5,094 | -5,550 | -6,160 | -7,086 |
| Net Income Continuous | -3,854 | -5,094 | -5,550 | -6,160 | -7,086 |
| Net Income | $-3,854 | $-5,094 | $-5,550 | $-6,160 | $-7,086 |
| EPS Basic Total Ops | -0.85 | -1.24 | -2.10 | -1.11 | -4.49 |
| EPS Basic Continuous Ops | -0.85 | -1.24 | -2.00 | -1.13 | -4.49 |
| EPS Diluted Total Ops | -0.85 | -1.24 | -2.10 | -1.11 | -4.49 |
| EPS Diluted Continuous Ops | -0.85 | -1.24 | -2.00 | -1.13 | -4.49 |
| EPS Diluted Before Non-Recurring Items | -0.85 | -1.24 | -2.10 | -1.20 | -4.50 |
| EBITDA(a) | $-3,440 | $-4,417 | $-4,991 | $-5,522 | $-6,419 |